Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 404

    1.

    Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.

    Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsuneyoshi M, Maehara Y, Sugimachi K, Kuwano M.

    Clin Cancer Res. 2000 Jun;6(6):2401-7.PMID: 10873092 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.

    Tada Y, Wada M, Migita T, Nagayama J, Hinoshita E, Mochida Y, Maehara Y, Tsuneyoshi M, Kuwano M, Naito S.

    Int J Cancer. 2002 Apr 1;98(4):630-5.PMID: 11920626 [PubMed - indexed for MEDLINE]Related articles

    3.

    Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.

    Haga S, Hinoshita E, Ikezaki K, Fukui M, Scheffer GL, Uchiumi T, Kuwano M.

    Jpn J Cancer Res. 2001 Feb;92(2):211-9.PMID: 11223551 [PubMed - indexed for MEDLINE]Related articles

    4.

    ATP-binding cassette superfamily transporter gene expression in human soft tissue sarcomas.

    Oda Y, Saito T, Tateishi N, Ohishi Y, Tamiya S, Yamamoto H, Yokoyama R, Uchiumi T, Iwamoto Y, Kuwano M, Tsuneyoshi M.

    Int J Cancer. 2005 May 10;114(6):854-62.PMID: 15609299 [PubMed - indexed for MEDLINE]Related articles

    5.

    Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.

    David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG.

    Int J Oncol. 2000 Dec;17(6):1077-86.PMID: 11078791 [PubMed - indexed for MEDLINE]Related articles

    6.

    Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.

    Young LC, Campling BG, Cole SP, Deeley RG, Gerlach JH.

    Clin Cancer Res. 2001 Jun;7(6):1798-804.PMID: 11410522 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.

    Noma B, Sasaki T, Fujimoto Y, Serikawa M, Kobayashi K, Inoue M, Itsuki H, Kamigaki M, Minami T, Chayama K.

    Int J Oncol. 2008 Dec;33(6):1187-94.PMID: 19020751 [PubMed - indexed for MEDLINE]Related articles

    8.

    Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.

    Rau S, Autschbach F, Riedel HD, Konig J, Kulaksiz H, Stiehl A, Riemann JF, Rost D.

    Eur J Clin Invest. 2008 Feb;38(2):134-42.PMID: 18226047 [PubMed - indexed for MEDLINE]Related articles

    9.

    ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.

    Ohishi Y, Oda Y, Uchiumi T, Kobayashi H, Hirakawa T, Miyamoto S, Kinukawa N, Nakano H, Kuwano M, Tsuneyoshi M.

    Clin Cancer Res. 2002 Dec;8(12):3767-75.PMID: 12473588 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.

    Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.

    Int J Cancer. 2002 Feb 20;97(6):751-60.PMID: 11857350 [PubMed - indexed for MEDLINE]Related articles

    11.

    Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.

    Nakamura T, Sakaeda T, Ohmoto N, Tamura T, Aoyama N, Shirakawa T, Kamigaki T, Nakamura T, Kim KI, Kim SR, Kuroda Y, Matsuo M, Kasuga M, Okumura K.

    Drug Metab Dispos. 2002 Jan;30(1):4-6.PMID: 11744604 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.

    Nies AT, König J, Pfannschmidt M, Klar E, Hofmann WJ, Keppler D.

    Int J Cancer. 2001 Nov;94(4):492-9.PMID: 11745434 [PubMed - indexed for MEDLINE]Related articles

    13.

    RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

    Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K.

    Clin Cancer Res. 2003 Feb;9(2):827-36.PMID: 12576456 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.

    Hu Y, Stephen AG, Cao J, Tanzer LR, Slapak CA, Harrison SD, Devanarayan V, Dantzig AH, Starling JJ, Rome LH, Moore RE.

    Int J Cancer. 2002 Jan 10;97(2):149-56.PMID: 11774257 [PubMed - indexed for MEDLINE]Related articles

    15.

    Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer.

    Endo K, Maehara Y, Kusumoto T, Ichiyoshi Y, Kuwano M, Sugimachi K.

    Int J Cancer. 1996 Nov 4;68(3):372-7.PMID: 8903480 [PubMed - indexed for MEDLINE]Related articles

    16.

    Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.

    Young LC, Campling BG, Voskoglou-Nomikos T, Cole SP, Deeley RG, Gerlach JH.

    Clin Cancer Res. 1999 Mar;5(3):673-80.PMID: 10100721 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.

    Oda Y, Ohishi Y, Saito T, Hinoshita E, Uchiumi T, Kinukawa N, Iwamoto Y, Kohno K, Kuwano M, Tsuneyoshi M.

    J Pathol. 2003 Feb;199(2):251-8.PMID: 12533839 [PubMed - indexed for MEDLINE]Related articles

    19.

    Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport.

    Uchiumi T, Hinoshita E, Haga S, Nakamura T, Tanaka T, Toh S, Furukawa M, Kawabe T, Wada M, Kagotani K, Okumura K, Kohno K, Akiyama S, Kuwano M.

    Biochem Biophys Res Commun. 1998 Nov 9;252(1):103-10.PMID: 9813153 [PubMed - indexed for MEDLINE]Related articles

    20.

    Multidrug resistance-associated protein subfamily transporters and drug resistance.

    Kuwano M, Toh S, Uchiumi T, Takano H, Kohno K, Wada M.

    Anticancer Drug Des. 1999 Apr;14(2):123-31. Review.PMID: 10405639 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data